SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Advanced Enzyme Technologies picks up additional stake in JC Biotech

19 Aug 2021 Evaluate

Advanced Enzyme Technologies has completed acquisition of additional stake of 15% in JC Biotech, subsidiary (JCB) by way of purchase of 31,06,680 Equity Shares from few selling shareholders of JCB, for a consideration of Rs 21.13 crore i.e. Rs 68 per equity share.

In view of this, the shareholding of the company in JCB has increased from 70% to 85% of paid-up share capital of JCB.

Advanced Enzyme Technologies is a research driven company with global leadership in manufacturing of enzymes and probiotics. It is the largest Indian enzyme company engaged in the research and development, manufacturing and marketing of vast proprietary products developed from many indigenous enzymes & probiotics.

Advanced Enzyme Share Price

298.95 0.35 (0.12%)
22-Apr-2026 12:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.00
Dr. Reddys Lab 1220.65
Cipla 1234.55
Zydus Lifesciences 930.80
Lupin 2304.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×